Innovative Grain-of-Rice Sensor Enhances Robotic and Medical Capabilities
A new sensor, comparable in size to a grain of rice, promises to significantly improve the functionality of robots and medical devices by measuring forces and twisting motions using light.
Capricor Therapeutics Claims Nippon Shinyaku Delays Duchenne Drug Rollout
Capricor Therapeutics has raised concerns about Nippon Shinyaku and its U.S. branch regarding the implementation of a treatment for Duchenne muscular dystrophy.
Innovative Nanoparticles Tackle Drug-Resistant Cancer Challenges
Recent findings highlight the potential of nanoparticles in fighting drug-resistant cancer, offering new hope for improving chemotherapy outcomes through advanced treatment methods.
Colorado Takes Initiative on Vaccine Accessibility Amid Federal Retreat
In response to a reduction in federal involvement, Colorado is actively reforming laws to improve vaccine access, igniting discussions on their importance.
Key Biotech Updates: Lawsuits and Regulatory Challenges
Today's biotech news highlights a lawsuit concerning Duchenne therapy and challenges faced by FDA Commissioner Marty Makary in relation to the White House.
Understanding the GENEROUS Model and Its Potential Effects on Medicaid Drug Pricing
This brief outlines the GENEROUS model and explores various elements that may influence Medicaid drug costs, emphasizing the importance of confidentiality regarding certain model details.
New Research Suggests Constipation Drug May Help Slow Kidney Disease Progression
A recent study indicates that lubiprostone, a medication typically used for constipation, may play a role in slowing the progression of chronic kidney disease in patients.
Tensions Rise as U.S. and Iran Exchange Fire During Ceasefire
As a month-old ceasefire hangs in the balance, the U.S. and Iran have exchanged fire. Meanwhile, Tennessee takes the lead in redrawing its U.S. House map following a Supreme Court decision.
Tracking the MV Hondius: A Critical Medical Mission
The MV Hondius is on a vital journey from Cabo Verde to the Canary Islands to assist in medical operations related to a hantavirus outbreak.
Energy Fuels: A Comprehensive Look at Uranium, Rare Earths, and Medical Isotopes
Energy Fuels is positioning itself as a key player in the nuclear energy sector with a diverse portfolio that includes uranium, rare earth elements, and medical isotopes.
Innovative Manganese Nanoparticle Therapy Shows Promise for Cancer Treatment
Researchers from the University of Michigan and MD Anderson Cancer Center have developed a novel nanoparticle therapy that may enhance cancer immunotherapy's safety and efficacy.
Concerns Rise Over Political Interference in FDA Drug Approvals
Recent developments suggest that a political appointee may be obstructing the approval process for a Sanofi drug, raising alarms about potential political interference at the FDA.
Sanofi Withdraws Teplizumab from FDA Fast-Track Review Amid Internal Disagreements
Sanofi has requested the FDA to withdraw teplizumab from its fast-track review program following internal disagreements regarding the drug's approval.
FDA to Reassess Ebvallo After Unexpected Rejection
Following a surprising rejection, the FDA will revisit the treatment for a rare cancer, as the developers of Ebvallo have reached an agreement to tackle the concerns raised.
Angelini Pharma Acquires Catalyst Pharmaceuticals for $4.1 Billion
In a significant move within the pharmaceutical industry, Angelini Pharma has announced its acquisition of Catalyst Pharmaceuticals, a company specializing in treatments for rare diseases, for $4.1 billion.
Contradictions in Trump Administration's Drug Policy Raise Concerns
The Trump administration's recent actions regarding drug policy appear inconsistent, as the White House endorses treatment methods while imposing new restrictions.
Bacterial protein map could open new path against drug-resistant infections
La Trobe scientists have made a pivotal discovery in the fight against dangerous drug-resistant bacteria.
The Case for 'Most Favored Nation' Drug Pricing: A Timely Discussion
As discussions around pharmaceutical pricing evolve, the 'Most Favored Nation' model emerges as a potential solution worth considering for its implications and benefits.
Sanofi Seeks FDA Withdrawal of Diabetes Drug from Fast-Track Review Amid Political Concerns
In a notable move, Sanofi has requested the FDA to withdraw its type 1 diabetes drug from the expedited review process, citing political interference as a key factor.
Medical Evacuation from MV Hondius Amid Hantavirus Concerns
Three individuals, including a Dutch passenger and two crew members, were evacuated from the MV Hondius over suspected hantavirus infection, with the operation coordinated by Dutch authorities.